title: Apoptosis therapy: driving cancers down the road to ruin.
authors: Douglas R
authors: DR
authors: Green
authors: Henning
authors: H
authors: Walczak
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology*; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D019253:Proto-Oncogene Proteins c-bcl-2; D013449:Sulfonamides; C579720:venetoclax
references: Mol Cell. 2010 Feb 12;37(3):299-310
references: 20159550
references: Cell. 2012 Oct 12;151(2):344-55
references: 23063124
references: Cancer Res. 2008 May 1;68(9):3421-8
references: 18451170
references: Nature. 2010 Feb 18;463(7283):899-905
references: 20164920
references: Cell. 2007 Mar 23;128(6):1173-86
references: 17382885
references: Nat Chem Biol. 2012 Jul;8(7):639-45
references: 22634637
references: Nature. 2005 Jun 2;435(7042):677-81
references: 15902208
references: Cancer Cell. 2006 Nov;10(5):389-99
references: 17097561
references: Nat Med. 2013 Feb;19(2):202-8
references: 23291630